Patrick G. Lepore, Director at VYNE Therapeutics Inc. (VYNE), bought 12,500 shares at $1.02 ($13K) on 2021-11-30, disclosed to the SEC on 2021-12-02.
Scheduled purchase ($13k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VYNE | BUY | 2023-03-22 | $50K | — | Filing → |
| LCI | BUY | 2022-11-14 | $49K | — | Filing → |
| LCI | BUY | 2022-05-17 | $27K | — | Filing → |